Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase 4 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 3Patient Compliance 1Pancreatic Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Oxaliplatin 56Capecitabine 49Fluorouracil 37Cisplatin 37S 1 (combination) 23Paclitaxel 18Docetaxel 18Leucovorin 16pembrolizumab 13Irinotecan 12apatinib 11titanium silicide 9XELOX 9Trastuzumab 9Nivolumab 9Hyperthermic Intraperitoneal Chemotherapy 8Epirubicin 8Drug Therapy 8Tegafur 7Radiotherapy 6Neoadjuvant Therapy 6gimeracil 5Surgical Procedures, Operative 5Gastrectomy 5Chemotherapy, Adjuvant 5tislelizumab 4S-1 plus cisplatin 4Ramucirumab 4zolbetuximab 3sintilimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Stomach Neoplasms × potassium oxonate × Clear all
NCT01515748 2023-12-13

PRODIGY

Sanofi

Phase 3 Completed
530 enrolled 11 charts
Gastrointestinal

Stomach Neoplasms

NCT02008422 2013-12-11

Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer

Xinjiang Medical University

Phase 3 Unknown
120 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01198392 2011-07-25

Trial of S-1 Plus Cisplatin in Gastric Cancer

Sun Yat-sen University

Phase 3 Unknown
270 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡